Childhood Obsessive- Compulsive Disorder

被引：6
作者：
Schuyler, McKenzie [1 ]
Geller, Daniel A. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Psychiat, 185 Cambridge St,Suite 2000, Boston, MA 02114 USA
[2] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA
来源：
PSYCHIATRIC CLINICS OF NORTH AMERICA | 2023年 / 46卷 / 01期
关键词：
Obsessive-compulsive disorder; Child and adolescent; Pediatric; Development; Psychopathology; COGNITIVE-BEHAVIORAL THERAPY; GENOME-WIDE ASSOCIATION; FAMILY ACCOMMODATION; CLINICAL-FEATURES; FUNCTIONAL IMPAIRMENT; PSYCHOMETRIC PROPERTIES; TREATMENT RESPONSE; GENDER-DIFFERENCES; SWEDISH CHILDREN; TIC DISORDERS;
D O I：
10.1016/j.psc.2022.10.002
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：89 / 106
页数：18
相关论文
共 120 条
  • [31] 2-3
  • [32] A quick and reliable screening measure for OCD in youth: reliability and validity of the obsessive compulsive scale of the Child Behavior Checklist
    Geller, DA
    Doyle, R
    Shaw, D
    Mullin, B
    Coffey, B
    Petty, C
    Vivas, F
    Biederman, J
    [J]. COMPREHENSIVE PSYCHIATRY, 2006, 47 (03) : 234 - 240
  • [33] Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial
    Geller, DA
    Wagner, KD
    Emslie, G
    Murphy, T
    Carpenter, DJ
    Wetherhold, E
    Perera, P
    Machin, A
    Gardiner, C
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (11) : 1387 - 1396
  • [34] Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder
    Geller, DA
    Biederman, J
    Stewart, SE
    Mullin, B
    Martin, A
    Spencer, T
    Faraone, SV
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (11) : 1919 - 1928
  • [35] Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder?
    Geller, DA
    Coffey, B
    Faraone, S
    Hagermoser, L
    Zaman, NK
    Farrell, CL
    Mullin, B
    Biederman, J
    [J]. CNS SPECTRUMS, 2003, 8 (04) : 259 - 264
  • [36] Impact of Comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: Is the use of exclusion criteria empirically supported in randomized clinical trials?
    Geller, DA
    Biederman, J
    Stewart, SE
    Mullin, B
    Farrell, C
    Wagner, KD
    Emslie, G
    Carpenter, D
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 : S19 - S29
  • [37] Developmental aspects of obsessive compulsive disorder: Findings in children, adolescents, and adults
    Geller, DA
    Biederman, J
    Faraone, S
    Agranat, A
    Cradock, K
    Hagermoser, L
    Kim, G
    Frazier, J
    Coffey, BJ
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2001, 189 (07) : 471 - 477
  • [38] Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial
    Geller, DA
    Hoog, SL
    Heiligenstein, JH
    Ricardi, RK
    Tamura, R
    Kluszynski, S
    Jacobson, JG
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (07) : 773 - 779
  • [39] Geller DA, 2001, INT J NEUROPSYCHOPH, V4, P169, DOI 10.1017/S1461145701002395
  • [40] Geller DA, 2018, WORLD J BIOL PSYCHIA, P1
12345678910